MedTrace Logo

Effectiveness of Virtual Reality Vision Therapy - VERVE

NCT04691427 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-04-16

No results posted yet for this study

Summary

The purpose of this research study is to see how well the treatment of a participant's eye coordination and/or focusing problems improves eye muscle responses and symptoms of eyestrain. We will use an entertainment device called a virtual reality headset to play a custom-designed video game to find out how well the treatment of binocular vision improves a participant's coordination and/or focusing problem. The virtual reality headset uses eye-trackers to monitor progress in a totally objective manner. Objective testing allows the doctor to determine the results without relying on a participant's ability to answer questions or respond verbally in any way. We will compare the results of a participant before and after playing the video game.

Conditions

  • Convergence Insufficiency

Interventions

DEVICE

Virtual Eye Rotation Vision Exercises (VERVE)

A video game designed with elements of vision therapy will be delivered to participants utilizing consumer-available virtual reality headsets (VIVE Pro Eye).

Sponsors & Collaborators

  • New Jersey Institute of Technology

    collaborator OTHER

  • Salus University

    collaborator OTHER

  • OculoMotor Technologies

    lead INDUSTRY

Principal Investigators

  • Chang Yaramothu, PhD · OculoMotor Technologies

  • Tara L Alvarez, PhD · OculoMotor Technologies

  • Mitchell M Scheiman, OD, PhD · OculoMotor Technologies

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
9 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-14
Primary Completion
2024-08-28
Completion
2024-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04691427 on ClinicalTrials.gov